Clinical Trial Update: Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a treatment for recalcitrant pruritus in patients with cutaneous T-cell lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Snippet

Sponsor: University of Minnesota | Conditions: Cutaneous T-Cell Lymphoma | Phase 1, Phase 2 | Status: TERMINATED